Literature DB >> 10867596

Interleukin-10 secretion by alveolar macrophages and monocytes in sarcoidosis.

R Bingisser1, R Speich, A Zollinger, E Russi, K Frei.   

Abstract

BACKGROUND: Alveolitis and the production of proinflammatory cytokines are known features of sarcoidosis. Because of the usually spontaneous resolution of alveolitis despite local secretion of mediators causing inflammation and granuloma formation, we hypothesized that downmodulating mechanisms such as anti-inflammatory cytokines might be involved in this process.
OBJECTIVE: Investigation of the secretion of the macrophage deactivating cytokines interleukin-10 (IL-10) and transforming growth factor-beta (TGF-beta) by alveolar macrophages in untreated sarcoidosis of the lung.
METHODS: Fourteen consecutive and untreated patients with pulmonary sarcoidosis and 18 volunteers underwent bronchoscopy. Alveolar macrophages (AM) were obtained by bronchoalveolar lavage and the secretion of IL-10 and TGF-beta was studied.
RESULTS: Spontaneous IL-10 production by AM was found in 6 of 14 patients and in 2 of 18 controls. The IL-10 level of lipopolysaccharide-stimulated AM was significantly higher in patients. Monocytes secreted significantly more IL-10 than AM, but there was no difference between sarcoid and control monocytes. No difference was found in the secretion of TGF-beta between patients and controls.
CONCLUSION: Increased local secretion of IL-10 - but not TGF-beta - may represent a downmodulating mechanism involved in the spontaneous resolution of alveolitis in sarcoidosis. Copyright 2000 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10867596     DOI: 10.1159/000029511

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  13 in total

1.  Sarcoidosis: still a mystery?

Authors:  T B Pierce; M Margolis; M A Razzuk
Journal:  Proc (Bayl Univ Med Cent)       Date:  2001-01

2.  IL-10: Another therapeutic target in idiopathic pulmonary fibrosis?

Authors:  A B Millar
Journal:  Thorax       Date:  2006-10       Impact factor: 9.139

3.  Alveolar macrophage function is altered in patients with lung cancer.

Authors:  D S Pouniotis; M Plebanski; V Apostolopoulos; C F McDonald
Journal:  Clin Exp Immunol       Date:  2006-02       Impact factor: 4.330

4.  In vitro and in vivo reactivity to fungal cell wall agents in sarcoidosis.

Authors:  M Terčelj; S Stopinšek; A Ihan; B Salobir; S Simčič; B Wraber; R Rylander
Journal:  Clin Exp Immunol       Date:  2011-10       Impact factor: 4.330

5.  CCL18 production is decreased in alveolar macrophages from cigarette smokers.

Authors:  Florian Kollert; Corina Probst; Joachim Müller-Quernheim; Gernot Zissel; Antje Prasse
Journal:  Inflammation       Date:  2009-06       Impact factor: 4.092

6.  Increased interleukin-13 expression in patients with sarcoidosis.

Authors:  H-P Hauber; D Gholami; A Meyer; A Pforte
Journal:  Thorax       Date:  2003-06       Impact factor: 9.139

7.  Serum amyloid A regulates granulomatous inflammation in sarcoidosis through Toll-like receptor-2.

Authors:  Edward S Chen; Zhimin Song; Matthew H Willett; Shannon Heine; Rex C Yung; Mark C Liu; Steve D Groshong; Ying Zhang; Rubin M Tuder; David R Moller
Journal:  Am J Respir Crit Care Med       Date:  2009-11-12       Impact factor: 21.405

8.  The role of T lymphocytes in cancer patients undergoing immunotherapy with autologous dendritic cells.

Authors:  Cláudia M Rodrigues; Bruna F Matias; Eddie F C Murta; Márcia A Michelin
Journal:  Clin Med Insights Oncol       Date:  2011-04-25

9.  Lack of association between IL10 polymorphisms and sarcoidosis in Japanese patients.

Authors:  Kenichi Sakuyama; Akira Meguro; Masao Ota; Mami Ishihara; Riyo Uemoto; Haruyasu Ito; Eiichi Okada; Kenichi Namba; Nobuyoshi Kitaichi; Shin-ichiro Morimoto; Toshikatsu Kaburaki; Yasutaka Ando; Shinobu Takenaka; Takenosuke Yuasa; Shigeaki Ohno; Hidetoshi Inoko; Nobuhisa Mizuki
Journal:  Mol Vis       Date:  2012-01-25       Impact factor: 2.367

10.  LPS induces IL-10 production by human alveolar macrophages via MAPKinases- and Sp1-dependent mechanisms.

Authors:  Hugues Chanteux; Amélie C Guisset; Charles Pilette; Yves Sibille
Journal:  Respir Res       Date:  2007-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.